Citigroup Inc Vertex Pharmaceuticals Inc Transaction History

Citigroup Inc

$163 Billion
Q4 2024

A detailed history of Citigroup Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 462,068 shares of VRTX stock, worth $222 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

462,068

Previous 588,420 21.47%

Holding current value

$222 Million

Previous $274 Million 32.01%

% of portfolio

0.11%

Previous 0.16%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$396.64 - $516.74 $50.1 Million - $65.3 Million	-126,352 Reduced 21.47%	462,068 $186 Million
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $50.1 Million - $55 Million	108,813 Added 22.69%	588,420 $274 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $31.4 Million - $38.8 Million	79,839 Added 19.97%	479,607 $225 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $22.4 Million - $24.5 Million	-54,824 Reduced 12.06%	399,768 $167 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $3.09 Million - $3.69 Million	8,995 Added 2.02%	454,592 $185 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $5.88 Million - $6.31 Million	-17,399 Reduced 3.76%	445,597 $155 Million
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $12 Million - $13.4 Million	38,119 Added 8.97%	462,996 $163 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $16.9 Million - $19.3 Million	-59,620 Reduced 12.31%	424,877 $134 Million
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $358,914 - $403,778	1,256 Added 0.26%	484,497 $140 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $99,947 - $111,518	365 Added 0.08%	483,241 $140 Million
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $8.26 Million - $10.3 Million	-35,160 Reduced 6.79%	482,876 $136 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $31.3 Million - $36.9 Million	-141,335 Reduced 21.43%	518,036 $135 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $14.1 Million - $17.8 Million	79,762 Added 13.76%	659,371 $145 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $105 Million - $118 Million	579,609 New	579,609 $105 Million

Others Institutions Holding VRTX

# of Institutions

1,752

Shares Held

227M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $123B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account